Column without a label
NOAC high dose subgroup rivaroxaban, dabigatran
NOAC high dose subgroup rivaroxaban, apixaban
NOAC high dose subgroup dabigatran, apixaban
Medications that increase bleeding risk without interaction
Medications that inhibit metabolism of NOACs and increase bleeding risk
Medications that induce metabolism of NOACs and reduce bleeding risk